Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

English (EN)·Polski (PL)·Ukraiński (UK)
Przejdź do strony domowej biblioteki Uniwersytet Ekonomiczny we Wrocławiu Link otwiera się w nowym oknie Logo biblioteki Prolib Integro - strona głównaUniwersytet Ekonomiczny we Wrocławiu

Wyszukujesz frazę ""Wang, Hongjie"" wg kryterium: Autor

  Lista filtrów
Wyrównaj
    Wyświetlanie 1-9 z 9
    Tytuł:
    Stabilization of endogenous Nrf2 by minocycline protects against Nlrp3-inflammasome induced diabetic nephropathy.
    Autorzy:
    Shahzad K; Institute of Clinical Chemistry and Pathobiochemistry, Otto-von-Guericke-University, 39120 Magdeburg, Germany.; University of Health Sciences, Khayaban-e-Jamia Punjab, 54600, Lahore, Pakistan.
    Bock F; Institute of Clinical Chemistry and Pathobiochemistry, Otto-von-Guericke-University, 39120 Magdeburg, Germany.; Department of Medicine, Vanderbilt University Medical Center, 37232 Nashville, Tennessee, United States.
    Al-Dabet MM; Institute of Clinical Chemistry and Pathobiochemistry, Otto-von-Guericke-University, 39120 Magdeburg, Germany.
    Gadi I; Institute of Clinical Chemistry and Pathobiochemistry, Otto-von-Guericke-University, 39120 Magdeburg, Germany.
    Nazir S; Institute of Clinical Chemistry and Pathobiochemistry, Otto-von-Guericke-University, 39120 Magdeburg, Germany.
    Wang H; Institute of Clinical Chemistry and Pathobiochemistry, Otto-von-Guericke-University, 39120 Magdeburg, Germany.; Department of Cardiology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
    Kohli S; Institute of Clinical Chemistry and Pathobiochemistry, Otto-von-Guericke-University, 39120 Magdeburg, Germany.
    Ranjan S; Institute of Clinical Chemistry and Pathobiochemistry, Otto-von-Guericke-University, 39120 Magdeburg, Germany.
    Mertens PR; Clinic of Nephrology and Hypertension, Diabetes and Endocrinology, Otto-von-Guericke University Magdeburg, 39120 Magdeburg, Germany.
    Nawroth PP; Department of Internal Medicine I and Clinical Chemistry, German Diabetes Center (DZD), University of Heidelberg, 69120 Heidelberg, Germany.
    Isermann B; Institute of Clinical Chemistry and Pathobiochemistry, Otto-von-Guericke-University, 39120 Magdeburg, Germany.
    Pokaż więcej
    Źródło:
    Scientific reports [Sci Rep] 2016 Oct 10; Vol. 6, pp. 34228. Date of Electronic Publication: 2016 Oct 10.
    Typ publikacji:
    Journal Article; Research Support, Non-U.S. Gov't
    MeSH Terms:
    Diabetes Mellitus, Experimental/*prevention & control
    Diabetic Nephropathies/*prevention & control
    Inflammasomes/*metabolism
    Minocycline/*pharmacology
    NF-E2-Related Factor 2/*metabolism
    NLR Family, Pyrin Domain-Containing 3 Protein/*metabolism
    Animals ; Diabetes Mellitus, Experimental/genetics ; Diabetes Mellitus, Experimental/metabolism ; Diabetic Nephropathies/genetics ; Diabetic Nephropathies/metabolism ; Diabetic Nephropathies/pathology ; Mice ; Mice, Knockout ; NF-E2-Related Factor 2/genetics ; Protein Stability/drug effects
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknieSzczegóły
    Tytuł:
    Chemical profiling analysis of Maca using UHPLC-ESI-Orbitrap MS coupled with UHPLC-ESI-QqQ MS and the neuroprotective study on its active ingredients.
    Autorzy:
    Zhou Y; Institute of Chinese Materia Medica, Academy of Chinese Medical Sciences, Beijing, China.
    Li P; Institute of Chinese Medical Sciences, University of Macau, Macau, China.
    Brantner A; Institute of Pharmaceutical Sciences Pharmacognosy, University of Graz, Graz, Austria.
    Wang H; Institute of Chinese Materia Medica, Academy of Chinese Medical Sciences, Beijing, China.
    Shu X; Shandong Rosemed Biopharm LTC, Yanzhou, Shandong province, China.
    Yang J; Institute of Chinese Materia Medica, Academy of Chinese Medical Sciences, Beijing, China.
    Si N; Institute of Chinese Materia Medica, Academy of Chinese Medical Sciences, Beijing, China.
    Han L; Institute of Chinese Materia Medica, Academy of Chinese Medical Sciences, Beijing, China.
    Zhao H; Institute of Chinese Materia Medica, Academy of Chinese Medical Sciences, Beijing, China.
    Bian B; Institute of Chinese Materia Medica, Academy of Chinese Medical Sciences, Beijing, China.
    Pokaż więcej
    Źródło:
    Scientific reports [Sci Rep] 2017 Mar 17; Vol. 7, pp. 44660. Date of Electronic Publication: 2017 Mar 17.
    Typ publikacji:
    Journal Article; Research Support, Non-U.S. Gov't
    MeSH Terms:
    Spectrometry, Mass, Electrospray Ionization*
    Chromatography, High Pressure Liquid/*methods
    Lepidium/*chemistry
    Neuroprotective Agents/*pharmacology
    Animals ; Biological Products/chemistry ; Biological Products/pharmacology ; Cholinesterase Inhibitors/pharmacology ; Dopaminergic Neurons/drug effects ; Dopaminergic Neurons/metabolism ; Dopaminergic Neurons/pathology ; Limit of Detection ; Neuroprotective Agents/chemistry ; Zebrafish
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknieSzczegóły
    Tytuł:
    Factors associated with acute cardiac injury and their effects on mortality in patients with COVID-19.
    Autorzy:
    He X; Department of Cardiology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430030, China.
    Wang L; Heart Center, Peking University Peoples Hospital, Beijing, China.
    Wang H; Department of Cardiology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430030, China.
    Xie Y; Department of Cardiology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430030, China.
    Yu Y; Department of Clinical Epidemiology, Aarhus University Hospital, Arhus, Denmark.
    Sun J; Department of Cardiology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430030, China.
    Yan J; Medical Research Institute, Wuhan University Renmin Hospital, Wuhan University, Wuhan, 430060, China.
    Du Y; Medical Research Institute, Wuhan University Renmin Hospital, Wuhan University, Wuhan, 430060, China.
    Shen Y; Medical Research Institute, Wuhan University Renmin Hospital, Wuhan University, Wuhan, 430060, China. .
    Zeng H; Department of Cardiology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430030, China. .
    Pokaż więcej
    Źródło:
    Scientific reports [Sci Rep] 2020 Nov 24; Vol. 10 (1), pp. 20452. Date of Electronic Publication: 2020 Nov 24.
    Typ publikacji:
    Journal Article; Research Support, Non-U.S. Gov't
    MeSH Terms:
    Hospital Mortality*
    COVID-19/*epidemiology
    COVID-19/*mortality
    Heart Injuries/*epidemiology
    Heart Injuries/*mortality
    SARS-CoV-2/*genetics
    SARS-CoV-2/*immunology
    Acute Disease ; Adult ; Aged ; Aged, 80 and over ; Biomarkers/blood ; C-Reactive Protein/analysis ; COVID-19/blood ; COVID-19/virology ; China/epidemiology ; Comorbidity ; Female ; Heart Injuries/blood ; Humans ; Incidence ; Male ; Middle Aged ; Natriuretic Peptide, Brain/blood ; Peptide Fragments/blood ; Prognosis ; Retrospective Studies ; Risk Factors ; Severity of Illness Index ; Troponin I/blood ; Young Adult
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
    Tytuł:
    Translational development of a tumor junction opening technology.
    Autorzy:
    Kim J; Division of Medical Genetics, School of Medicine, University of Washington, Seattle, WA, USA.; PAI Life Sciences, Seattle, WA, USA.
    Li C; Division of Medical Genetics, School of Medicine, University of Washington, Seattle, WA, USA.
    Wang H; Division of Medical Genetics, School of Medicine, University of Washington, Seattle, WA, USA.
    Kaviraj S; Gennova Biopharmaceuticals, Ltd, Pune, India.
    Singh S; Gennova Biopharmaceuticals, Ltd, Pune, India.
    Savergave L; Gennova Biopharmaceuticals, Ltd, Pune, India.
    Raghuwanshi A; Gennova Biopharmaceuticals, Ltd, Pune, India.
    Gil S; Division of Medical Genetics, School of Medicine, University of Washington, Seattle, WA, USA.
    Germond A; Washington National Primate Research Center, Seattle, WA, USA.
    Baldessari A; Washington National Primate Research Center, Seattle, WA, USA.
    Chen B; Institute of Biomedical Sciences, Academia Sinica, Taipei, Taiwan.
    Roffler S; Institute of Biomedical Sciences, Academia Sinica, Taipei, Taiwan.
    Fender P; CNRS, Univ. Grenoble Alpes, CEA, UMR5075, Institut de Biologie Structurale, 38042, Grenoble, France.
    Drescher C; Public Health Sciences Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
    Carter D; Division of Medical Genetics, School of Medicine, University of Washington, Seattle, WA, USA.; PAI Life Sciences, Seattle, WA, USA.; Department of Global Health, School of Public Health, University of Washington, Seattle, WA, USA.
    Lieber A; Division of Medical Genetics, School of Medicine, University of Washington, Seattle, WA, USA. .; Department of Pathology, School of Medicine, University of Washington, Box 357720, Seattle, WA, 98195, USA. .
    Pokaż więcej
    Źródło:
    Scientific reports [Sci Rep] 2022 May 11; Vol. 12 (1), pp. 7753. Date of Electronic Publication: 2022 May 11.
    Typ publikacji:
    Journal Article; Research Support, U.S. Gov't, Non-P.H.S.; Research Support, Non-U.S. Gov't; Research Support, N.I.H., Extramural
    MeSH Terms:
    Ovarian Neoplasms*/drug therapy
    Ovarian Neoplasms*/pathology
    Animals ; Antineoplastic Combined Chemotherapy Protocols/therapeutic use ; Cyclophosphamide/therapeutic use ; Doxorubicin ; Female ; Humans ; Mice ; Recombinant Proteins/therapeutic use ; Technology ; Tight Junctions/pathology
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
    Tytuł:
    Effects of perioperative exercise on cardiorespiratory endurance in children with congenital heart disease in plateau areas after surgical repair.
    Autorzy:
    Qi R; Division of Cardiology, Department of Internal Medicine, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, No. 1095, Jiefang Avenue, Wuhan, Hubei, China.; Hubei Provincial Engineering Research Centre of Vascular Interventional Therapy, Wuhan, China.; Department of Cardiology, Zhengzhou Cardiovascular Hospital, Henan Medical Key Laboratory of Arrhythmia, Zhengzhou, China.
    Liu S; Division of Cardiology, Department of Internal Medicine, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, No. 1095, Jiefang Avenue, Wuhan, Hubei, China.; Hubei Provincial Engineering Research Centre of Vascular Interventional Therapy, Wuhan, China.
    Wang H; Division of Cardiology, Department of Internal Medicine, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, No. 1095, Jiefang Avenue, Wuhan, Hubei, China.; Hubei Provincial Engineering Research Centre of Vascular Interventional Therapy, Wuhan, China.
    He X; Division of Cardiology, Department of Internal Medicine, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, No. 1095, Jiefang Avenue, Wuhan, Hubei, China.; Hubei Provincial Engineering Research Centre of Vascular Interventional Therapy, Wuhan, China.
    Liu W; Division of Cardiology, Department of Internal Medicine, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, No. 1095, Jiefang Avenue, Wuhan, Hubei, China.; Hubei Provincial Engineering Research Centre of Vascular Interventional Therapy, Wuhan, China.
    Huang F; Division of Cardiology, Department of Internal Medicine, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, No. 1095, Jiefang Avenue, Wuhan, Hubei, China.; Hubei Provincial Engineering Research Centre of Vascular Interventional Therapy, Wuhan, China.
    Zhao Y; Department of Cardiology, Zhengzhou Cardiovascular Hospital, Henan Medical Key Laboratory of Arrhythmia, Zhengzhou, China.
    Yang B; Department of Cardiology, Zhengzhou Cardiovascular Hospital, Henan Medical Key Laboratory of Arrhythmia, Zhengzhou, China.
    Xu S; Department of Cardiology, Peking University Third Hospital, NHC Key Laboratory of Cardiovascular Molecular Biology and Regulatory Peptides, Key Laboratory of Molecular Cardiovascular Science, Ministry of Education, 49 North Garden Road, Beijing, 100191, China. .
    Zeng H; Division of Cardiology, Department of Internal Medicine, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, No. 1095, Jiefang Avenue, Wuhan, Hubei, China. .; Hubei Provincial Engineering Research Centre of Vascular Interventional Therapy, Wuhan, China. .
    Pokaż więcej
    Źródło:
    Scientific reports [Sci Rep] 2023 Oct 23; Vol. 13 (1), pp. 18088. Date of Electronic Publication: 2023 Oct 23.
    Typ publikacji:
    Randomized Controlled Trial; Journal Article; Research Support, Non-U.S. Gov't
    MeSH Terms:
    Exercise*
    Heart Defects, Congenital*/surgery
    Humans ; Child ; Exercise Therapy ; Exercise Test ; Walking ; Oxygen Consumption
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
      Wyświetlanie 1-9 z 9

      Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies